Search results
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 6 hours agoMirae Asset Global Investments Co. Ltd. trimmed its stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 3.4% during the fourth quarter, according to its most recent 13F filing ...
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
Technology Networks· 5 days agoTreatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall...
Janux a new buy at Jones on lead assets for solid tumors
Seeking Alpha· 7 days agoJones Trading initiates Janux Therapeutics at buy, citing the promise behind the company's...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 16 hours agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Janux Therapeutics (NASDAQ:JANX) Now Covered by Analysts at Jonestrading
ETF DAILY NEWS· 6 days agoA number of other research firms have also weighed in on JANX. Cantor Fitzgerald assumed coverage on Janux Therapeutics in a research note on Wednesday, March 20th. William Blair reiterated ...
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65
ETF DAILY NEWS· 6 days agoJanux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $52.65, but opened at $51.05. Janux Therapeutics ...
Nisa Investment Advisors LLC Has $29,000 Position in Janux Therapeutics, Inc. (NASDAQ:JANX)
ETF DAILY NEWS· 6 hours agoNisa Investment Advisors LLC lifted its position in Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) by 10,740.0% during the fourth quarter, according to its most recent 13F filing with ...
Strs Ohio Raises Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 3 days agoStrs Ohio raised its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 9.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned ...
Analysts Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $251.70
ETF DAILY NEWS· 1 day agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports ...
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Zacks via Yahoo Finance· 7 days agoXTX202, on the other hand, is being developed in a phase II study to treat patients with metastatic ...
